The Pathogenesis of Type-2-Diabetes Glycotoxicity and the Role of Carbohydrates

被引:0
|
作者
Joost, H. -G. [1 ]
机构
[1] Deutsch Inst Ernahrungsforschung Potsdam Rehbruck, Arthur Scheunert Allee 114-116, Nuthetal, Germany
来源
AKTUELLE ERNAHRUNGSMEDIZIN | 2006年 / 31卷
关键词
Type-2-diabetes; glucose toxicity; insulin resistance; diet;
D O I
10.1055/s-2005-915366
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type-2 diabetes is the result of insulin resistance, usually associated with obesity, and a progredient beta-cell failure. It is generally believed that b-cell dysfunction is caused by external factors, and three different noxious agents have been proposed: elevated blood glucose levels (,,glucotoxicity"), fatty acids and/or triglycerides accumulating in the beta-cells (,,lipotoxicity"), and inflammatory cytokines from adipose tissue. This review summarizes the available evidence for the glucotoxicity concept, in particular with regard to the role of dietary carbohydrates. The data are consistent with the hypothesis that postprandial glucose excursions are a major factor in the development of type-2 diabetes. However, a dietary intervention reducing the glycemic load is probably less effective in reducing the diabetes risk than a reduction of body fat.
引用
收藏
页码:S37 / S41
页数:5
相关论文
共 50 条
  • [1] Metformin and it's role in the management of type-2-diabetes
    Haupt, E
    Panten, U
    MEDIZINISCHE KLINIK, 1997, 92 (08) : 472 - 479
  • [2] The role of the Microbiota in the development of Obesity and Type-2-Diabetes
    Simon, M. C.
    Muessig, K.
    DIABETOLOGIE UND STOFFWECHSEL, 2015, 10 (01) : R1 - R11
  • [3] Gene Type-2-Diabetes A Portal helps to understand Type-2-Diabetes better
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2016, 25 (04): : 258 - 258
  • [4] Prevention of the Type-2-Diabetes
    Stefan, N.
    Fritsche, A.
    Haering, H. -U.
    DIABETOLOGIE UND STOFFWECHSEL, 2008, 3 (04) : R57 - R68
  • [5] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Aberle, Jens
    Birkenfeld, Andreas L.
    Gallwitz, Baptist
    Kellerer, Monika
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Siegel, Erhard
    DIABETOLOGE, 2021, 17 (04): : 422 - 447
  • [6] Therapy of Type-2-Diabetes
    Landgraf, Ruediger
    Kellerer, Monika
    Fach, Eva-Maria
    Gallwitz, Baptist
    Hamann, Andreas
    Joost, Hans-Georg
    Klein, Harald
    Mueller-Wieland, Dirk
    Nauck, Michael A.
    Reuter, Hans-Martin
    Schreiber, Stephan
    Siegel, Erhard
    DIABETOLOGIE UND STOFFWECHSEL, 2017, 12 : S141 - S156
  • [7] Type-2-Diabetes in Adolescence
    Pavlicek, V.
    DIABETOLOGE, 2012, 8 (05): : 412 - 413
  • [8] Amyloid Formation in Type-2-Diabetes
    不详
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (08) : 442 - 442
  • [9] Early detection of Type-2-Diabetes
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2019, 28 (03): : 156 - 156
  • [10] Customized treatment of Type-2-Diabetes
    不详
    DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (05): : 277 - 278